Treatment of thyroid carcinoma: emphasis on high-dose 131I outpatient therapy
KL Parthasarathy, ES Crawford - Journal of Nuclear Medicine …, 2002 - Soc Nuclear Med
There is an abundance of evidence indicating that the oral administration of sodium 13II-
iodide is of value in the management of well-differentiated thyroid cancers. The first step in …
iodide is of value in the management of well-differentiated thyroid cancers. The first step in …
Radioactivity appearing at landfills in household trash of nuclear medicine patients: Much ado about nothing?
JA Siegel, RB Sparks - Health physics, 2002 - journals.lww.com
The US NRC in 1997 removed its arbitrary 1.11 GBq (30 mCi) rule, which had been in
existence for almost 50 y, and now many more patients receiving radionuclide therapy in …
existence for almost 50 y, and now many more patients receiving radionuclide therapy in …
[PDF][PDF] Radioprotection using iodine-131 for thyroid cancer and hyperthyroidism: a review
IA Al-Shakhrah - Clin J Oncol Nurs, 2008 - researchgate.net
Issa A. Al-Shakhrah, PhD, is an associate professor in medical physics in the Physics
Department at the University of Jordan in Amman. No financial relationships to disclose …
Department at the University of Jordan in Amman. No financial relationships to disclose …
Reactors, radioisotopes, and the HIFAR controversy
J Green - 1997 - ro.uow.edu.au
This thesis concerns a controversy as to whether Australia's one operating nuclear research
reactor, HIFAR, should be replaced with anew reactor. HIFAR will almost certainly be …
reactor, HIFAR, should be replaced with anew reactor. HIFAR will almost certainly be …